Skip to main content

Peer Review reports

From: Blocking CCR5 activity by maraviroc augmentation in post-stroke depression: a proof-of-concept clinical trial

Original Submission
16 Oct 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
24 Oct 2023 Author responded Author comments - Einor Ben Assayag
Resubmission - Version 3
24 Oct 2023 Submitted Manuscript version 3
12 Feb 2024 Reviewed Reviewer Report
26 Mar 2024 Author responded Author comments - Einor Ben Assayag
Resubmission - Version 4
26 Mar 2024 Submitted Manuscript version 4
30 Mar 2024 Author responded Author comments - Einor Ben Assayag
Resubmission - Version 5
30 Mar 2024 Submitted Manuscript version 5
15 Apr 2024 Reviewed Reviewer Report
1 May 2024 Reviewed Reviewer Report
5 May 2024 Author responded Author comments - Einor Ben Assayag
Resubmission - Version 6
5 May 2024 Submitted Manuscript version 6
17 May 2024 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
20 May 2024 Editorially accepted
6 Jun 2024 Article published 10.1186/s12883-024-03683-3

You can find further information about peer review here.

Back to article page